Moolec Science (MLEC) Accumulated Expenses (2022 - 2025)
Moolec Science (MLEC) reported Accumulated Expenses of $129468.0 for Q4 2025, up 48229.37% on a YoY basis from N/an in Q4 2024, and down 46.86% sequentially from $243634.0 in Q2 2025.
Moolec Science (MLEC) Accumulated Expenses (2022 - 2025) Analysis & Trends
Moolec Science (MLEC) has 4 years of Accumulated Expenses data on file, last reported at $129468.0 in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Expenses rose 48229.37% year-over-year to $129468.0; the trailing twelve-month figure through Dec 2025 stood at $129468.0 (up 48229.37% YoY), and the FY2025 full-year result was $243634.0, down 96.75% from the prior year.
- Accumulated Expenses retreated to $129468.0 in Q4 2025, from $243634.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $10.0 million in Q2 2023 to a low of -$269.0 in Q4 2024.
- A 4-year average of $3.1 million and a median of $364684.5 in 2022 frame the typical range for Accumulated Expenses.
- Peak annual rise in Accumulated Expenses reached 48229.37% in 2025, while the deepest fall reached 96.75% in 2025.
- Tracing MLEC's Accumulated Expenses over 4 years: stood at $485735.0 in 2022, then jumped by 1948.62% to $10.0 million in 2023, then tumbled by 100.0% to -$269.0 in 2024, then jumped by 48229.37% to $129468.0 in 2025.
- Business Quant data shows MLEC's Accumulated Expenses at $129468.0 in Q4 2025, $243634.0 in Q2 2025, and -$269.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 129,468.00 |
| Jun 30, 2025 | 243,634.00 |
| Dec 31, 2024 | -269.00 |
| Jun 30, 2024 | 7.51 Mn |
| Jun 30, 2023 | 9.95 Mn |
| Jun 30, 2022 | 485,735.00 |